Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.65 |
| ▸ | RAB9A | P51151 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | KCNJ1 | P48048 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | MGLL | Q99685 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9610816 | 1.00 | KDM4E (0.65) | KDM4ESMN1; SMN2MAPK1NPC1NR2F2 | |
| SCHEMBL20680703 | 0.89 | KDM4E (0.53) | KDM4ESMN1; SMN2MAPK1NPC1NR2F2 | |
| SCHEMBL13833154 | 0.87 | KDM4E (0.60) | KDM4ESMN1; SMN2MAPK1NPC1NR2F2 | |
| SCHEMBL8715859 | 0.85 | KCNJ1 (0.77) | KCNJ1 | |
| SCHEMBL8509511 | 0.85 | KCNJ1 (0.77) | KCNJ1 | |
| SCHEMBL28216327 | 0.85 | KDM4E (0.61) | KDM4ESMN1; SMN2MAPK1NPC1NR2F2 | |
| SCHEMBL6416345 | 0.85 | KDM4E (0.71) | KDM4ESMN1; SMN2MAPK1NPC1NR2F2 | |
| SCHEMBL5626457 | 0.84 | ALDH1A1 (0.74) | KDM4ESMN1; SMN2ALDH1A1LMNAMAPT | |
| SCHEMBL17985929 | 0.83 | KCNJ1 (0.56) | KDM4ESMN1; SMN2MAPK1NPC1NR2F2 | |
| SCHEMBL17986054 | 0.83 | KCNJ1 (0.74) | KCNJ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111511728-B | Compound for separating rare earth elements and s, p, d metals, separation method and use thereof | 有机生物化学公司 | 2023-12-08 | — | — | CN | claimed |
| US-20230227942-A1 | SEPARATION OF RARE EARTH ELEMENTS | SHINE TECHNOLOGIES, LLC | 2023-07-20 | — | — | US | claimed |
| CN-115836137-A | Separation of rare earth elements | 阳光科技公司 | 2023-03-21 | — | — | CN | claimed |
| EP-4127255-A1 | SEPARATION OF RARE EARTH ELEMENTS | SHINE Technologies, LLC (US) | 2023-02-08 | — | — | EP | claimed |
| EP-3717466-B1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2022-01-05 | — | — | EP | claimed |
| US-20200282331-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2020-09-10 | — | — | US | claimed |
| EP-3492460-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS, METHOD OF SEPARATION, AND USE THEREOF | Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. (CZ) | 2019-06-05 | — | — | EP | claimed |
| EP-0292689-A2 | Substituted 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclo-dodecane and analogs | BRACCO INTERNATIONAL B.V. (NL) | 1988-11-30 | — | — | EP | claimed |
| US-20250229198-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I (CZ) | 2025-07-17 | — | — | US | disclosed |
| US-12268977-B2 | Compounds for separation of rare earth elements and s-, p-, d-metals, method of separation, and use thereof | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR. V.V.I. (CZ) | 2025-04-08 | — | — | US | disclosed |
| CN-111511728-B | Compound for separating rare earth elements and s, p, d metals, separation method and use thereof | 有机生物化学公司 | 2023-12-08 | — | — | CN | disclosed |
| US-20230227942-A1 | SEPARATION OF RARE EARTH ELEMENTS | SHINE TECHNOLOGIES, LLC | 2023-07-20 | — | — | US | disclosed |
| CN-115836137-A | Separation of rare earth elements | 阳光科技公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-4127255-A1 | SEPARATION OF RARE EARTH ELEMENTS | SHINE Technologies, LLC (US) | 2023-02-08 | — | — | EP | disclosed |
| US-5846519-A | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs | BRACCO DIAGNOSTICS INC. (US) | 1998-12-08 | — | — | US | disclosed |
| US-5674470-A | Method for imaging mammalian tissue using 1-substituted- 4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs | BRACCO DIAGNOSTICS INC. (US) | 1997-10-07 | — | — | US | disclosed |
| EP-0292689-B1 | Substituted 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclo-dodecane and analogs | BRACCO INT BV (NL) | 1996-07-31 | — | — | EP | disclosed |
| US-5474756-A | Chelate compound of a paramagnetic ion of lanthanide element | BRACCO INTERNATIONAL B.V. (NL) | 1995-12-12 | — | — | US | disclosed |
| US-4885363-A | RADIOPHARMACEUTICAL IMAGING; MEDICAL DIAGNOSIS | E. R. SQUIBB & SONS, INC. (US) | 1989-12-05 | — | — | US | disclosed |
| EP-0292689-A2 | Substituted 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclo-dodecane and analogs | BRACCO INTERNATIONAL B.V. (NL) | 1988-11-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250229198-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | SCO2, SOD3, SLC39A3 | KDM4E 4827/4885SMN1; SMN2 2494/4885MAPK1 3558/4885 |
| US-20200282331-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | SCLY, SFXN1, PTCD3 | KDM4E 4511/4885SMN1; SMN2 1716/4885MAPK1 2906/4885 |
| US-12268977-B2 | Compounds for separation of rare earth elements and s-, p-, d-metals, method of separation, and use thereof | SCLY, SFXN1, PTCD3 | KDM4E 4511/4885SMN1; SMN2 1716/4885MAPK1 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.